companydata.dkcompanydata.dk
SearchPricingAPI
companydata.dkcompanydata.dk

Free company lookup with financials, ownership and key figures for all Danish companies.

Overview

  • Municipalities
  • Postal codes
  • Industries
  • Countries
  • Top 100 companies
  • Top lists
  • Business news
  • Check company
  • Find owner
  • Financial data
  • Credit rating
  • Credit report
  • Background check

Links

  • Search
  • Pricing
  • Company profile
  • Monitoring
  • Lead List Generator
  • Screening
  • CVR Enrichment
  • Network search
  • Statstidende
  • Guides
  • Glossary
  • Compare alternatives

Integrations

  • API
  • MCP-server
  • Claude
  • ChatGPT
  • Perplexity
  • Mistral Le Chat
  • Gemini
  • Zapier
  • Dinero
  • e-conomic

Who it's for

  • For you
  • For accountants
  • For investors
  • For sales teams
  • For lawyers
  • For journalists

Legal

  • Privacy Policy
  • Terms of Service
  • Information Letter
  • Contact

© 2026 companydata.dk

Ebumab Sandbox ApS

CVR: 43575627

Established (3 yrs)Loss-making
Active
Own this company?

About Ebumab Sandbox ApS

Ebumab Sandbox ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Hans Heugh Wandall and Johan Henrik Faber. The company is owned by Ebumab Holding ApS. In 2025, the company reported a gross profit of DKK -12,630 and a net result of DKK -11,150 compared with DKK -7,800 the year before. Equity amounted to DKK 15,192.

Your company? Claim the profile and show your logo, website and social channels — for free.

Claim this profile

Overview

Company type
APS
Anpartsselskab
Address
Ole Maaløes Vej 3, 2200 København N
KØBENHAVN
2200 København N
Find nearby companies
Founded
12.10.2022

Details

Industry
Fremstilling af farmaceutiske præparater
Code: 212000
Capital
40.000 kr.

Contact

Advertising protected

Purpose

Selskabets formål er drive virksomhed indenfor forskning, udvikling og markedsføring af farmaceutiske og medicinske præparater samt anden efter bestyrelsens skøn beslægtet virksomhed.

Location

Google Maps|Apple Maps|OpenStreetMap

Financials

YearGross ProfitProfit/LossTotal AssetsEquityEmployeesReport
2025-13 t.-11 t.15 t.15 t.0
2024-10 t.-8 t.26 t.26 t.0

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Industry Benchmarks

View industry report

Compared to 129 companies in Fremstilling af farmaceutiske præparater

Employees
Company0
Industry median12
100% below
Equity ratio
Company100.0%
Industry median62.0%
61% above

Comparison is based on industry median values

Ownership

Owners
Ebumab Holding ApS
CVR: 39807556
100%
Ebumab Sandbox ApS
CVR: 43575627

Management

Directors

Hans Heugh Wandall(ADM. DIR.)
Johan Henrik Faber(DIREKTØR)

Board

Thomas Dal Stenfeldt Batchelor(FORMAND)
Hans Heugh Wandall(BESTYRELSESMEDLEM)
Johan Henrik Faber(BESTYRELSESMEDLEM)
Søren Erik Bjørn(BESTYRELSESMEDLEM)

PEP screening

Screen owners and management against the Danish FSA's official PEP lists

Founders

Ebumab Holding ApS

Production units (1)

Ebumab Sandbox ApS
P-no: 1028659144
Ole Maaløes Vej 3, 2200, København N
Fremstilling af farmaceutiske præparater

Is this your company?

Free

Claim this page to add your logo and social links. Free to get started.

  • Verified badge on your profile
  • Upload your logo
  • Links to your website and social channels

History

14 events
2026
Ebumab Sandbox ApS: The 2025 annual report is outJun 22, 2026

Ebumab Sandbox ApS has published its annual report for 2025. Gross profit came to DKK -12,630, and the net result was DKK -11,150.

2025
Ebumab Sandbox ApS: The 2024 annual report is outJun 20, 2025

Ebumab Sandbox ApS has published its annual report for 2024. Gross profit came to DKK -10,000, and the net result was DKK -7,800.

Ebumab Sandbox ApS appoints new auditorFeb 25, 2025

As of February 25, 2025, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Ebumab Sandbox ApS.

Auditor steps down at Ebumab Sandbox ApSFeb 25, 2025

As of February 25, 2025, Slotsgade Revision ApS has stepped down as auditor of Ebumab Sandbox ApS.

2024
Ebumab Sandbox ApS publishes interim reportJun 29, 2024

Ebumab Sandbox ApS has published its interim report for the period October 12, 2022 – December 31, 2023.

2022
Ebumab Sandbox ApS appoints new auditorOct 12, 2022

As of October 12, 2022, Slotsgade Revision ApS has been appointed auditor of Ebumab Sandbox ApS.

Hans Heugh Wandall joins the board of Ebumab Sandbox ApSOct 12, 2022

As of October 12, 2022, Hans Heugh Wandall has joined the board of directors of Ebumab Sandbox ApS.

Johan Henrik Faber joins the board of Ebumab Sandbox ApSOct 12, 2022

As of October 12, 2022, Johan Henrik Faber has joined the board of directors of Ebumab Sandbox ApS.

Søren Erik Bjørn joins the board of Ebumab Sandbox ApSOct 12, 2022

As of October 12, 2022, Søren Erik Bjørn has joined the board of directors of Ebumab Sandbox ApS.

Thomas Dal Stenfeldt Batchelor joins the board of Ebumab Sandbox ApSOct 12, 2022

As of October 12, 2022, Thomas Dal Stenfeldt Batchelor has joined the board of directors of Ebumab Sandbox ApS.

Hans Heugh Wandall joins Ebumab Sandbox ApS as adm. dir.Oct 12, 2022

As of October 12, 2022, Hans Heugh Wandall is registered as adm. dir. of Ebumab Sandbox ApS.

Johan Henrik Faber joins Ebumab Sandbox ApS as directorOct 12, 2022

As of October 12, 2022, Johan Henrik Faber is registered as director of Ebumab Sandbox ApS.

Ebumab Holding ApS registered as owner of Ebumab Sandbox ApSOct 12, 2022

As of October 12, 2022, Ebumab Holding ApS is registered as an owner of Ebumab Sandbox ApS with an ownership share of 100%.

Ebumab Sandbox ApS is foundedOct 12, 2022

Ebumab Sandbox ApS was founded on October 12, 2022.

Similar companies

Companies in the same industry and area

Antag Therapeutics ApS

CVR 38402056

Fremstilling af farmaceutiske præparater266 mKØBENHAVN5-9 employees

Cymab ApS

CVR 39859173

Fremstilling af farmaceutiske præparater266 mKØBENHAVN

Beo Therapeutics ApS

CVR 39880377

Fremstilling af farmaceutiske præparater266 mKØBENHAVN

Zyneyro ApS

CVR 42057428

Fremstilling af farmaceutiske præparater266 mKØBENHAVN

FimmCyte ApS

CVR 43432583

Fremstilling af farmaceutiske præparater266 mKØBENHAVN